Article in Kidney360, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 41% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
1 citing paper in PubMed, 1 citations in OpenAlex.
Iman KhanDivision of Nephrology and Hypertension, Department of Medicine, Weill Cornell Medicine, New York, New York.
Sylvia WuDivision of Nephrology and Hypertension, Department of Medicine, Weill Cornell Medicine, New York, New York.
Anika HudsonDivision of Nephrology and Hypertension, Department of Medicine, Weill Cornell Medicine, New York, New York.ORCID 0009-0007-4161-0947
Clayton HughesDivision of Nephrology and Hypertension, Department of Medicine, Weill Cornell Medicine, New York, New York.
Gabriel StryjniakDivision of Nephrology and Hypertension, Department of Medicine, Weill Cornell Medicine, New York, New York.
Lars F WestbladeDepartment of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York.
Michael J SatlinDepartment of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York.
Nicholas TedrowDivision of Nephrology and Hypertension, Department of Medicine, Weill Cornell Medicine, New York, New York.ORCID 0009-0006-1468-6594
Anne-Catrin UhlemannDivision of Infectious Diseases, Department of Medicine, Vagelos College of Physicians and Surgeons Columbia University, New York, New York.ORCID 0000-0002-9798-4768
Colleen KraftDivision of Infectious Diseases, Department of Medicine, Emory University School of Medicine, New York, New York.
Darshana M DadhaniaDivision of Nephrology and Hypertension, Department of Medicine, Weill Cornell Medicine, New York, New York.ORCID 0000-0002-7973-1521
Jeffrey SilberzweigDivision of Nephrology and Hypertension, Department of Medicine, Weill Cornell Medicine, New York, New York.ORCID 0000-0002-2381-7043
Iwijn De VlaminckNancy E. and Peter C. Meinig School of Biomedical Engineering, Cornell University, Ithaca, New York.ORCID 0000-0001-6085-7311
Carol LiDivision of Nephrology and Hypertension, Department of Medicine, Weill Cornell Medicine, New York, New York.
Vesh SrivatanaDivision of Nephrology and Hypertension, Department of Medicine, Weill Cornell Medicine, New York, New York.ORCID 0000-0003-2998-6451
John Richard LeeDivision of Nephrology and Hypertension, Department of Medicine, Weill Cornell Medicine, New York, New York.ORCID 0000-0002-9612-5742
Emory University · USNewYork–Presbyterian Hospital · US
Funding
Cell-Free DNA in Peritoneal Fluid as a Novel and Versatile Analyte for Monitoring PeritonitisR21AI164093 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI DE VLAMINCK, IWIJN, LEE, JOHN RICHARD · 2021 to 2022
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
A Distinct Nasal Microbiota Signature in Peritoneal Dialysis Patients. · full record | OpenQuestion